Biological Therapy Analysis & Statistics, July 2014 (p6)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

151-180 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
G-CSF Inhibitors -Pipeline Insights, 2014

G-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“G-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Biological Therapy
Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists -Pipeline Insights, 2014

Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hedgehog Signaling Pathway Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Integrase Inhibitors -Pipeline Insights, 2014

Integrase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Integrase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2014

Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Biological Therapy
Notch Signaling Pathway Inhibitors -Pipeline Insights, 2014

Notch Signaling Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Notch Signaling Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
T Cell Inhibitors -Pipeline Insights, 2014

T Cell Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“T Cell Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2014

Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Wnt Signaling Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2014

GM-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GM-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry

Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...

  • Industries : Biological Therapy
  • Countries : World
World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • June 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Critical Limb Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
  • Countries : World
International Stem Cell Corporation - Product Pipeline Review - 2014

International Stem Cell Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

International Stem Cell Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘International Stem Cell Corporation - Product Pipeline Review - 2014', provides an overview of the ...

  • Industries : Biological Therapy
  • Countries : World
Stem Cells -- 6 Dimensional Assessment (Technical Insights)

Stem Cells -- 6 Dimensional Assessment (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

The clinical translation of regenerative cells The scope of this research service comprises research within the area of adult and embryonic stem cells, and developments in the nascent area of induced pluripotent ...

  • Industries : Biological Therapy
Aastrom Biosciences, Inc. (Symbol:ASTM) SWOT Analysis, Strategy, Revenues and Profits

Aastrom Biosciences, Inc. (Symbol:ASTM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
ReNeuron Group plc (Symbol:RENE) SWOT Analysis, Strategy, Revenues and Profits

ReNeuron Group plc (Symbol:RENE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based therapies to repair and rebuild diseased tissues and organs. It has developed a regenerative ...

  • Industries : Biological Therapy
  • Countries : United States
Degenerative Disc Disease - Pipeline Review, H1 2014

Degenerative Disc Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Degenerative Disc Disease - Pipeline Review, H1 2014', provides an overview of the Degenerative Disc Disease's therapeutic ...

  • Industries : Biological Therapy
  • Countries : World
Induced Pluripotent Stem Cells : Global Markets

Induced Pluripotent Stem Cells : Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stem Cell Research Market in India 2014

Stem Cell Research Market in India 2014

  • $ 950
  • Industry report
  • June 2014
  • by Netscribes (India) Pvt. Ltd.

Netscribes' latest market research report titled Stem Cell Research Market in India 2014 analyses how stem cell therapy is gaining importance in India as consumers realize the various benefits it offers. ...

  • Industries : Biological Therapy
  • Countries : India
BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biological Therapy
  • Countries : United States
Physician Views: Are neurologists ready to embrace gene therapy?

Physician Views: Are neurologists ready to embrace gene therapy?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

Description As recently noted by Forbes, the biotech bull market of 2013 has helped to revive an approach to drug development that had become largely abandoned and pursued by only a few devoted believers. ...

  • Industries : Biological Therapy
  • Countries : United States
Herceptin-Drug Insights,2014

Herceptin-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Herceptin - Drug Insights, 2014” provides Herceptin marketed details and API Manufacturers details across the globe along with the location. In addition, it ...

  • Industries : Biological Therapy
  • Countries : United States
Procrit-Drug Insights,2014

Procrit-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Procrit - Drug Insights, 2014” provides Procrit marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
Rituxan-Drug Insights,2014

Rituxan-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Rituxan - Drug Insights, 2014” provides Rituxan marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
Neupogen-Drug Insights,2014

Neupogen-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Neupogen - Drug Insights, 2014” provides Neupogen marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States

34 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.